交易信息汇总：7月4日，中工国际主力资金净流出1481.13万元，而游资资金净流入1074.68万元， 散户资金净流入406.45万元。 交易信息汇总 7月4日，中工国际的资金流向情况如下：主力资金净流出1481.13万元；游资资金净流入1074.68万元； 散户资金净流入406.45万元。 投资者： 公司在石油领域是否有布局 董秘： 您好！公司积极落实"十四五"战略规划，持续打造差异化、专业化的竞争优势，加大布局油气 工程"新赛道"。公司在中东油气工程领域取得重大突破的伊拉克九区油气中央处理设施项目（合同金额 约10亿美元）于2024年先后顺利实现油包、气包的成功投产，成为伊拉克油田开发史上首个原油与天然 气处理设施同时规划、建设并于同一年投产的标杆项目，创造了伊拉克同类项目最短工期和连续1,800 万安全工时的骄人纪录，获得伊拉克石油部的高度评价和赞誉。借助该项目所积累的良好口碑，公司 2024年再度签约伊拉克九区连井项目，并于2025年一季度一次性成功投产，再度扩大中工国际在中东油 气工程行业的品牌影响力。公司承接的土耳其图兹湖天然气储库二期项目，顺利完成机械竣工里程碑节 点，并于2025年3月签约该项 ...

当日关注点 交易信息汇总 7月3日，中工国际的资金流向情况如下：主力资金净流入652.58万元；游资资金净流入264.87万元；散 户资金净流出917.45万元。 公司公告汇总 截至2025年7月3日收盘，中工国际(002051)报收于8.58元，上涨0.12%，换手率1.18%，成交量14.57万 手，成交额1.25亿元。 董秘最新回复 投资者： 公司在AI医疗方面是否有布局 董秘： 您好！公司所属中国中元是国内首批获得工程设计综合甲级资质的企业，拥有全国综合实力最 强、专业人数最多的医疗建筑设计咨询团队，在医疗建筑领域具有突出的市场地位，参与了四分之一以 上的中国百强医院建设。近年来，随着人工智能的快速发展，中国中元着力推进包括医疗建筑在内的建 筑设计行业数智转型，打造了包括医疗建筑智能设计平台、AR数字沙盘等数智工具，利用人工智能技 术为业务赋能，不断巩固在医疗设计领域的技术优势与行业影响力。谢谢！ 投资者： 公司在海洋经济、海上风电方面是否有布局 董秘： 您好！公司所属中国中元发挥大科学领域咨询设计业务优势，持续助力国家海洋科学研究，完 成了中国海洋大学生命科学技术中心、深海科考中心和海南三亚中科院深 ...

Core Viewpoint - The company has approved a profit distribution plan for the fiscal year 2024, which includes a cash dividend of 1.25 RMB per 10 shares for all shareholders, with specific tax considerations for different types of investors [1][2]. Profit Distribution Plan - The profit distribution plan was approved at the annual shareholders' meeting on May 30, 2025, and is based on the total share capital as of December 31, 2024 [1]. - The cash dividend will be distributed as follows: 1.25 RMB per 10 shares before tax, and 1.125 RMB for certain investors after tax deductions [2]. - The distribution will be executed within two months of the approval date, and the total share capital has not changed since the announcement [1][2]. Tax Considerations - Different tax rates apply based on the type of shareholder, with specific provisions for Hong Kong investors and domestic investors holding different types of shares [2]. - The tax obligations for individual investors will be calculated based on their holding period, with no tax due for shares held over one year [2]. Shareholder Registration and Distribution Method - The record date for shareholders eligible for the dividend is July 9, 2025, and the distribution will occur on July 10, 2025 [3]. - Cash dividends will be directly credited to the shareholders' accounts through their custodial securities companies [3]. Consultation and Documentation - The company has provided contact information for inquiries regarding the profit distribution [4].

证券代码：002051 证券简称：中工国际 公告编号：2025－034 中工国际工程股份有限公司 2024 年度分红派息实施公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整， 没有虚假记载、误导性陈述或重大遗漏。 一、股东大会审议通过利润分配方案情况 中工国际工程股份有限公司（以下简称"公司"）2024 年度利 润分配方案于2025年5月30日经公司2024年度股东大会审议通过， 公司 2024 年度权益分派方案为：以 2024 年 12 月 31 日公司总股本 1,237,408,937股为基数，向全体股东每 10股派1.25元人民币现金（含 税），剩余未分配利润滚存至下年度。分配预案公布后至实施前，公 司总股本如因增发新股、股权激励行权、可转债转股等原因发生变 动的，将按照现金分红总额固定不变的原则，在利润分配实施公告 中披露按公司最新总股本计算的分配比例。 自分配方案披露至实施期间，公司股本总额未发生变化。 本次实施的分配方案与股东大会审议通过的分配方案及其调整 原则是一致的。 【注：根据先进先出的原则，以投资者证券账户为单位计算持股 期限，持股1个月（含1个月）以内，每10股补缴税款0. ...

Group 1 - TaiLong Pharmaceutical plans to apply for the registration and issuance of super short-term financing bonds not exceeding 800 million yuan, with a maturity of no more than 270 days, for purposes including replacing bank loans and supplementing working capital [1] - GuoXin Technology won a bid for a 46 million yuan automotive airbag ignition driver chip project, indicating its growing presence in the automotive semiconductor market [1] - GuoMai Technology expects a net profit increase of 60.52% to 100.33% for the first half of 2025, with a projected net profit of 125 million to 156 million yuan [2] Group 2 - ChangAluminum's subsidiary signed a 165 million yuan contract for the customized construction of a clinical and industrial base for a vaccine project, highlighting its involvement in the biopharmaceutical sector [3] - ZhongSalt Chemical acquired exploration rights for natural soda ash in Inner Mongolia for 929,000 yuan, expanding its resource base [4] - Six Kingdom Chemical announced the resignation of its deputy general manager, which may impact its operational strategy [5][6] Group 3 - FuYuan Pharmaceutical received a drug registration certificate for Bisoprolol Amlodipine tablets, indicating its expansion in the hypertension treatment market [7][8] - GuanShi Technology's subsidiary received a government subsidy of 7 million yuan, which is 45.29% of its net profit for the previous year, enhancing its financial position [9] - XiZhong Technology plans to repurchase shares worth between 75 million and 150 million yuan, aimed at employee stock ownership plans or equity incentives [10] Group 4 - BeiLu Pharmaceutical's subsidiary received approval for the raw material drug Iopromide, which is used as a contrast agent for various imaging examinations [12] - HongHui New Materials obtained a patent for a water-based protective paint for hardware parts, enhancing its product portfolio [13] - BoJi Pharmaceutical's subsidiary received two patents related to high bioavailability formulations, indicating innovation in biopharmaceutical technology [14] Group 5 - ChengJian Development received a cash dividend of 23.625 million yuan from its investment in Huaneng Capital, contributing to its investment income [15] - JiuZhou Pharmaceutical's subsidiary received a drug registration certificate for Sildenafil Citrate orally disintegrating tablets, expanding its product offerings in the erectile dysfunction treatment market [16] - RuiAng Gene's subsidiary received a government subsidy of 176,290 yuan, supporting its operational activities [17] Group 6 - FengFan Technology plans to acquire 100% equity of a subsidiary for 48 million yuan, indicating strategic expansion in the renewable energy sector [18] - AoJing Medical's subsidiary received a medical device production license, allowing it to manufacture absorbable surgical dressings [19] - TaiLin Bio's subsidiary won land use rights for an industrial site, facilitating its high-performance filter project [20] Group 7 - KaiPu Bio received a patent for a method and device for analyzing genomic copy number variations, enhancing its capabilities in molecular diagnostics [21] - Shanghai KaiBao received a drug registration certificate for Phlegm-Heat Clearing Capsules, which can be used in the treatment of COVID-19 symptoms [23] - TuoJing Life received two patents for high uniformity streptavidin applications, improving its diagnostic product stability [25] Group 8 - AnKe Bio's AK2024 injection received approval for clinical trials, marking a significant advancement in cancer treatment [26] - HuanYuan Pharmaceutical expects a net profit of 142 million to 160 million yuan for the first half of 2025, reflecting substantial growth [27] - JinHongShun terminated a major asset restructuring plan due to a lack of consensus among parties involved, impacting its strategic direction [28] Group 9 - HeZhan Energy signed a 177 million yuan contract for the sale of steel-concrete tower structures, indicating strong demand in the renewable energy sector [29] - InSai Group's acquisition plan for an 80% stake in ZhiZheTongXing was accepted by the Shenzhen Stock Exchange, indicating growth in its consulting business [30] - JiuDian Pharmaceutical received a drug registration certificate for Zinc Granules, enhancing its product line in gastrointestinal treatments [32] Group 10 - GuoYao Modern plans to publicly transfer a 51% stake in its subsidiary to optimize resource allocation [34] - GuoYao Modern's subsidiary received a drug registration certificate for Perindopril Indapamide tablets, expanding its hypertension treatment portfolio [36] - ZhongGong International signed a 175 million yuan engineering consulting service contract, showcasing its capabilities in project management [38] Group 11 - China Railway won contracts worth approximately 5.343 billion yuan for overseas construction projects, indicating its strong international presence [39] - JunPu Intelligent signed a framework contract for humanoid robot sales worth about 28.25 million yuan, reflecting growth in the robotics sector [41] - Sinopec's chairman resigned due to age, which may lead to changes in corporate governance [42] Group 12 - JiuFeng Energy's controlling shareholder plans to reduce their stake by up to 0.71%, indicating potential changes in ownership structure [44] - Zhejiang Oriental's subsidiary plans to establish a 1.74 billion yuan equity investment fund, focusing on strategic emerging industries [46] - ChenGuang New Materials received a government subsidy of 26 million yuan, significantly impacting its financial performance [48]

一、合同主要内容 河北省邯郸市百万蛋鸡农业科技产业园全过程工程咨询服务合同金额为17,544.03万元，该项目位于河北 省邯郸市，项目内容为咨询人向委托人提供全过程工程咨询服务，包括：项目管理、工程勘察、工程规 划及设计、工程监理、全过程造价咨询、招标代理、融资咨询和其他专项评价咨询。其中，京兴国际 （联合体牵头人）、中国中元和中元长春主要承担项目管理、工程监理、其他专项评价咨询，以及工程 规划及设计、工程勘察等工作，所承担的合同工作量对应合同金额为13,105.39万元（具体金额根据实际 完成的工作量据实计算）。服务期限为合同签订之日至该项目完成竣工验收和工程结算之日止。 二、交易对方情况介绍 河北省邯郸市百万蛋鸡农业科技产业园全过程工程咨询服务合同的交易对方为深圳宸可投资控股有限公 司，注册地址为深圳市宝安区新安街道海旺社区宝兴路88号星通大厦1507。该公司成立于2023年，为国 内领先的大型蛋品全产业链集团广东宸可资本控股集团有限公司的全资子公司。深圳宸可投资控股有限 公司与公司不存在关联关系，上一会计年度未与公司发生类似业务。 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、 ...

Company Announcements - Jihua Group's existing product system does not involve brain-computer interface related fields [1] - Prit's plan to invest 1 billion yuan to build a plastic modification materials headquarters and R&D manufacturing base in South China [1][2] - Lian De Equipment won a contract worth 157 million yuan for BOE's 8.6 generation AMOLED production line project [1][2] - Jiadu Technology plans to issue shares (H-shares) overseas and list on the Hong Kong Stock Exchange [1][2] - Longdi Group intends to acquire no more than 20.1667% equity in Jujia Technology [1][4] - New Zhonggang plans to repurchase shares worth 40 million to 80 million yuan [1][4] - Xiaogoods City expects a net profit increase of 12.57% to 17.40% in the first half of the year [1][4] - Sinopec Capital plans to reduce its holdings by no more than 3.5256 million shares in Haizheng Materials through block trading [1][4] - Lihua Co., Ltd. intends to reduce its holdings by no more than 3.00% [1][4] - Zhimin Da plans to raise no more than 213 million yuan through a private placement [1][5] - Xiangtong Co. plans to issue corporate bonds not exceeding 4 billion yuan [1][5] Performance Forecasts - Hanyu Pharmaceutical expects a half-year profit of 142 million to 162 million yuan, turning a profit compared to the previous year [4] - Taotao Automotive anticipates a net profit increase of 70.34% to 97.81% in the first half of the year [4] - Weichai Heavy Machinery expects a net profit increase of 40% to 60% in the first half of the year [4] Shareholding Changes - Lihua Co., Ltd.'s actual controller Cheng Lili and his concerted actors plan to reduce their holdings by no more than 3.00% [4] - He Shi Eye Hospital's Advanced Manufacturing Fund plans to reduce its holdings by no more than 2% [4] - Haitan Ruisheng's shareholder He Lin and his concerted actors plan to reduce their holdings by no more than 2.9463% [4] - Sinopec Capital plans to reduce its holdings by no more than 3.5256 million shares in Haizheng Materials [4] Other Announcements - Zhimin Da plans to raise no more than 213 million yuan through a private placement [5] - Yuyuan Co. plans to issue corporate bonds not exceeding 40 billion yuan [5] - Jinhongshun has terminated the planning of a major asset restructuring [5]

Core Viewpoint - Multiple listed companies in the Shanghai and Shenzhen stock markets have announced significant updates, including changes in financing, business performance, and strategic decisions, which may impact investor sentiment and market dynamics [1]. Financing and Restructuring - Guanhao Biological has withdrawn its application for refinancing, leading to the termination of the review process by the Shenzhen Stock Exchange [3]. - Jinhongshun has terminated its major asset restructuring plan due to a lack of consensus among parties involved [6]. - Yuyuan Co. plans to issue bonds not exceeding 40 billion yuan to adjust its debt structure and replenish working capital [23]. Business Performance and Uncertainties - Aored has highlighted significant uncertainties in its computing power leasing services due to heavy asset investment and potential market fluctuations [4]. - Guoyao Modern intends to publicly transfer 51% of its subsidiary Guoyao Hason's shares, as the subsidiary has been underperforming with continuous losses since 2021 [5]. - Chengbang Co. reported that its subsidiary, Xinchun Electronics, has a small business scale and faces intense competition in the semiconductor storage industry, with projected revenues of 111 million yuan and a net profit of 933,800 yuan for 2024 [9]. Stock Market Activity - Alloy Investment announced a change in its controlling shareholder to Jiuzhou Hengchang, with stock trading resuming on July 1 [7]. - Changcheng Military Industry reported significant stock price volatility, with a cumulative increase of over 100% in the last 10 trading days, indicating potential irrational market behavior [8]. Earnings Forecasts - Hanyu Pharmaceutical expects a net profit of 142 million to 160 million yuan for the first half of 2025, recovering from a loss in the previous year, driven by international business growth [12]. - Taotao Vehicle anticipates a net profit increase of 70.34% to 97.81% for the same period, reflecting strong sales performance [13]. - Weichai Heavy Machinery projects a net profit increase of 40% to 60%, benefiting from industry policy support and demand growth [15]. Major Contracts and Projects - China Railway has won contracts for overseas construction projects totaling approximately 5.343 billion yuan [17]. - Zhonggong International has signed a 175 million yuan engineering consulting service contract [18]. - Hezhan Energy has entered into a 177 million yuan contract for the sale of steel-concrete towers [19].

证券代码：002051 证券简称：中工国际 公告编号：2025－033 中工国际工程股份有限公司经营合同公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整， 没有虚假记载、误导性陈述或重大遗漏。 2025 年 6 月 30 日，中工国际工程股份有限公司（以下简称公司） 下属全资公司京兴国际工程管理有限公司（以下简称京兴国际）、下 属全资公司中国中元国际工程有限公司（以下简称中国中元）、下属 控股子公司中元国际（长春）高新建筑设计院有限公司（以下简称中 元长春），与丰汇（天津）项目管理有限公司（以下简称丰汇（天津）） 组成联合体，与深圳宸可投资控股有限公司签署了河北省邯郸市百万 蛋鸡农业科技产业园全过程工程咨询服务合同。 一、合同主要内容 河北省邯郸市百万蛋鸡农业科技产业园全过程工程咨询服务合 同金额为 17,544.03 万元，该项目位于河北省邯郸市，项目内容为咨 询人向委托人提供全过程工程咨询服务，包括：项目管理、工程勘察、 工程规划及设计、工程监理、全过程造价咨询、招标代理、融资咨询 和其他专项评价咨询。其中，京兴国际（联合体牵头人）、中国中元和 中元长春主要承担项目管理、工程监理、其他专项评 ...

截至2025年一季报，共有6家机构持仓中工国际，其中其他5家、基金1家，合计持股数80141.28万股， 持股市值64.67亿元。 从行业市盈率排名来看，公司所处的工程建设行业市盈率平均13.40倍，行业中值20.14倍，中工国际排 名第50位。 6月30日，中工国际今日收盘8.63元，下跌1.37%，滚动市盈率PE（当前股价与前四季度每股收益总和的 比值）达到28.44倍，总市值106.79亿元。 中工国际工程股份有限公司的主营业务是设计咨询与工程承包、先进工程技术装备开发与应用、工程投 资与运营。公司的主要产品是设计咨询与工程承包、先进工程技术装备开发与应用、工程投资与运营。 获得300余项国家及省部级科技成果奖，拥有全国索道专业甲级工程设计资质。其"客运脱挂架空索 道"入选工信部第七批制造业单项冠军产品名单、获得"机械工业优质品牌产品"荣誉称号；医疗仓储和 环保起重机械业务处于行业领先地位。 来源：金融界 最新一期业绩显示，2025年一季报，公司实现营业收入21.83亿元，同比-7.61%；净利润1.31亿元，同比 12.17%，销售毛利率19.72%。 序号股票简称PE(TTM)PE(静)市净率总市值 ...